The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we formulate using isolated to monoids but we join them together along with other constituents so we use less and we capitalize on the synergistic effects of a lot of the molecules no differently than what we do in medicine is an anesthesiologist we just don't push one medication we push a lot of different medications to lower the bad effects of one particular medicine and capitalize on the good effects of all of them
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I think what I'm really wanting in focus more about is a single molecule as opposed to looking at many of the molecules within the cannabis plant and try to find utilization you know so a single molecule like CBD from epidemics from GW Pharma came from a plant but it is isolated and purified to 99.99% and it requires a tremendous amount to get the effect that GW Pharma wanted to get on two types of seizures